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Brief Communication
L1.1 Is Involved in Spinal Cord Regeneration in
Adult Zebrafish
Catherina G. Becker, Bettina C. Lieberoth, Fabio Morellini, Julia Feldner, Thomas Becker, and Melitta Schachner
Zentrum fu¨r Molekulare Neurobiologie, Universita¨t Hamburg, D-20246 Hamburg, Germany
Adult zebrafish, in contrast to mammals, regrow axons descending from the brainstem after spinal cord transection. L1.1, a homolog of
the mammalian recognition molecule L1, is upregulated by brainstem neurons during axon regrowth. However, its functional relevance
for regeneration is unclear. Here, we show with a novel morpholino-based approach that reducing L1.1 protein expression leads to
impaired locomotor recovery as well as reduced regrowth and synapse formation of axons of supraspinal origin after spinal cord
transection. This indicates that L1.1 contributes to successful regrowth of axons from the brainstem and locomotor recovery after spinal
cord transection in adult zebrafish.
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Introduction
Axotomized neurons regenerating an axon show increased ex-
pression of so-called growth-associated genes, which may have
important functions for axon regrowth (for review, see Bulsara et
al., 2002; Plunet et al., 2002). One of these genes is L1, a ho-
mophilically and heterophilically binding cell surface protein of
the immunoglobulin superfamily of cell recognition molecules
that is involved in many aspects of nervous system development,
including axon growth and synaptic plasticity (for review, see
Haspel and Grumet, 2003). During peripheral nerve regenera-
tion, L1 is expressed in motor neurons and Schwann cells (Mar-
tini and Schachner, 1988; Zhang et al., 2000). In the mammalian
CNS, expression of L1 is increased in subpopulations of axoto-
mized neurons only when their axons regrow into a permissive
peripheral nerve graft (Zhang et al., 1995). Infusion of L1-Fc
fusion protein into the lesioned adult rat spinal cord promotes
locomotor recovery (Roonprapunt et al., 2003). These findings
indicate that increased expression of L1 may be relevant for axon
regrowth to occur.
In zebrafish, many axons, including those that project from
the brainstem to the spinal cord, regrow in the adult CNS after a
lesion, and fish spontaneously recover locomotor aptitude after
spinal lesion within several weeks (Becker et al., 1997). There are
two L1 homologs in zebrafish, designated L1.1 and L1.2 (Ton-
giorgi et al., 1995). As in mammals, increased expression of these
genes is tightly correlated with regenerative success of CNS axons
such as retinal ganglion cells (Bernhardt et al., 1996) or brainstem
neurons with spinal axons (Becker et al., 1998). Of the two ho-
mologs, L1.1 is most prominently upregulated after spinal cord
lesion. A detailed analysis of L1.1 expression in the brainstem
shows that the proportion of neurons in different brainstem nu-
clei that upregulate expression of L1.1 correlates with differences
in regenerative capacity of these nuclei (our unpublished obser-
vations; Becker et al., 1998).
To show directly that expression of L1.1 is a necessary com-
ponent of the regenerative response of brainstem neurons in
adult zebrafish, we used antisense morpholino oligonucleotides
(Nasevicius and Ekker, 2000; Heasman, 2002) to suppress expres-
sion of L1.1 during regeneration. We were able to efficiently apply
morpholinos by retrograde transport into the somata of axoto-
mized neurons in the brainstem of adult zebrafish, which leads to
reduced L1.1 protein expression in these neurons. Using retro-
grade axonal tracing and a behavioral test of locomotion, we
found that regrowth of axons from the brainstem and locomotor
recovery are both strongly impaired by the knockdown of L1.1,
indicating that this molecule is an important player in spinal cord
regeneration of a vertebrate.
Materials and Methods
Spinal cord lesion and application of tracers and morpholinos. All of the
animal experiments were approved by the University and State of Ham-
burg animal care committees. For regeneration experiments, spinal cords
were lesioned as described previously (Becker et al., 1997). Briefly, fish
were anesthetized by immersion in 0.033% aminobenzoic acid ethylm-
ethylester (MS222; Sigma, St. Louis, MO) for 5 min. A longitudinal inci-
sion was made at the side of the fish to expose the vertebral column. The
spinal cord was cut completely between two vertebrae, 4 mm caudal to
the brainstem–spinal cord junction.
L1.1 morpholino (5-ATGAAAACAGCCCCGACTCCAGACA-3)
and standard control morpholino (Gene Tools, Philomath, OR) were
dissolved in Danieau solution (Nasevicius and Ekker, 2000) at different
concentrations and were soaked onto small pieces of Gelfoam (Upjohn,
Kalamazoo, MI) at a volume of 6 l. These pieces of Gelfoam weredi-
vided into 30 smaller pieces to yield 100 – 800 ng of morpholino per piece
and were allowed to dry. Per fish, one of these pieces was applied to the
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spinal transection site immediately after the transection. The wound was
sealed with Histoacryl (B. Braun, Melsungen, Germany), and animals
were allowed to survive the operation for up to 6 weeks. We used
fluorescein-tagged and untagged morpholinos, which did not differ in
their activities.
In some fish, axon regrowth was blocked by inserting a piece of Teflon
tape (400 400 m; RS, Bad Hersfeld, Germany) at the spinal lesion
site. The absence of supraspinal neurons with regenerated spinal axons
was confirmed by retrograde tracing from a position caudal to the tran-
section site after the recovery period and behavioral testing for locomo-
tor activity at 6 weeks postlesion. A sham lesion was performed by open-
ing the epidermis and exposing the vertebral column, which was left
intact. Subsequently, the wound was sealed with Histoacryl.
The neuronal tracers biocytin (Sigma) and rhodamine dextran
(Sigma) were used as described previously (Becker et al., 1997). To quan-
tify regenerative success of brainstem neurons, horseradish peroxidase
(HRP) (Roche, Mannheim, Germany) was applied to one spinal hemi-
sphere from a position 8 mm caudal to the brainstem–spinal cord junc-
tion, which is 4 mm caudal to the spinal transection site. HRP labeling
was developed as described previously (Becker et al., 1997), and labeled
neuronal profiles were counted in vibratome sections (50 m thick) of
the brainstem. Analyzing spinal sections at the tracer application site
showed no labeling of longitudinal tracts on the contralateral, unlabeled
side, indicating that the tracer application was confined to one spinal
hemisphere. For profile counting, the experimenter was blinded to the
experimental treatment of individual fish.
Video tracking of freely moving fish. Swimming capabilities of fish at
different postlesion time points and after different treatments were ana-
lyzed in two trials of 5 min each (intertrial interval, 4 hr). In each trial, the
fish was placed in a brightly illuminated (100 lux) glass tank (50 30
30 cm) filled with aquarium water (5 cm deep; 25°C). Trials were re-
corded using a video camera above the tank. Swim paths were tracked
with Ethovision (Noldus, Wageningen, The Netherlands) software. Five
samples were taken per second, and 0.7 cm was the minimal distance
detected as movement between two consecutive samples. The mean of
the entire length of the swim paths (“total distance moved”) of the two
trials was used for graphical representation and statistical analysis. The
experimenter was blinded to the treatment of individual fish before
testing.
Immunohistochemistry. Immunohistochemistry with a polyclonal an-
tiserum against bacterially expressed zebrafish L1.1 (Becker et al., 2004)
was performed on free-floating vibratome sections (50 m thick) of
brainstem and spinal cord, as described previously (Becker et al., 2004).
Briefly, the sections were incubated with the antiserum (1:3000) over-
night, and antibody binding was detected with the appropriate secondary
cyanine-3-coupled antibodies (Dianova, Hamburg, Germany). For
quantification, L1.1-positive cell profiles were counted in the brainstem
using the 40 objective of an Axiophot (Zeiss, Oberkochen, Germany)
microscope. The relative fluorescence intensity of the diffuse immuno-
reactivity in the spinal cord was measured on digital photomicrographs
taken on the Axiophot microscope using ImageJ software (http://rsb.
info.nih.gov/ij/), as described previously (Becker et al., 2003). The exper-
imenter was blinded to the experimental treatments before counting cell
profiles and taking photomicrographs of spinal cord sections.
Western blot analysis. One millimeter pieces of spinal cord directly
caudal to the lesion site and 4 mm caudal to the lesion site were isolated
and subjected to standard Western blotting techniques, as described pre-
viously (Becker et al., 2003). The entire homogenate from one piece of
spinal tissue was used to load one gel pocket. Stripping the filters and
reprobing them with an anti-tubulin antibody (Sigma) served as a load-
ing control.
Electron microscopy. For electron microscopy of anterogradely labeled
synapses, biocytin was applied to the brainstem–spinal cord junction, as
described previously (Becker et al., 1997), and allowed to be transported
within axons over the spinal lesion site. Labeling was developed in 50m
sections, as described previously (Becker and Becker, 2001). Subse-
quently, sections were embedded in plastic resin, cut ultrathin (80 nm),
and analyzed on a Zeiss EM900 electron microscope according to stan-
dard procedures. Synapses were identified by their vesicle content and
the presence of a postsynaptic density. Labeled synapses of supraspinal
origin appeared much darker in the electron microscope than unlabeled
synapses of intraspinal origin (see Fig. 4e,f ). The mean of the total num-
ber of labeled synaptic profiles in the spinal gray matter of two to three
ultrathin sections, each from a different 50 m section per animal at a
distance of 6 mm from the brainstem–spinal cord junction, was deter-
mined and used for graphical representation. The experimenter was
blinded to the treatment of individual fish before counting synaptic
profiles.
Statistical analysis. Because data were not normally distributed and
different groups had unequal variances, nonparametric statistical analy-
ses were performed with the software GraphPad Prism 3.0 (GraphPad
Software, San Diego, CA) or StatView (SAS Institute, Cary, NC). Two
treatments were compared with the Mann–Whitney U test or  2 test. To
test the effect of more than two treatments, the Kruskal–Wallis test fol-
lowed by Dunn’s multiple comparisons test was used. Repeated measures
within the same subjects were tested with the Friedman test followed by
Dunn’s multiple comparisons test. All of the tests were two-tailed. Data
are presented as mean SEM.
Results
To establish the use of morpholinos in adult zebrafish, we first
tested whether morpholinos would be taken up by brainstem
neurons through their cut axons at a spinal lesion site, similar to
conventional neuronal tracers such as biocytin (Becker et al.,
1998). Application of fluorescein-tagged morpholinos (Fig. 1d)
or biocytin, soaked on a Gelfoam pledget immediately after
Figure 1. Morpholinos are retrogradely transported into neuronal somata in the brainstem and reduce L1.1 immunoreactivity. a–d, In a cross section through the NMLF, the number of
L1.1-immunopositive neurons is increased 10 d after a lesion ( b) compared with unlesioned controls ( a). Upregulation is greatly reduced when L1.1 morpholino is applied to the spinal lesion site ( c).
In the same tissue section ( d), accumulation of fluorescein-tagged L1.1 morpholino is visible with the appropriate filters. e, The number of L1.1-immunoreactive cell profiles is reduced by L1.1
morpholino compared with control morpholino-treated animals in a concentration-dependent manner (*p 0.05). Scale bar: (in d) a–d, 50m. Error bars represent SEM.
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spinal cord transection 4 mm caudal to the brainstem–spinal
cord junction, did not show differences in the distribution and
numbers of neuronal profiles specifically labeled in brainstem
nuclei with spinal projections (data not shown). The fluores-
cein signal was still detectable in brainstem neurons 6 weeks
after application. This indicates efficient retrograde transport
of morpholinos.
To analyze whether a morpholino directed against L1.1 spe-
cifically reduces the expression of the protein, immunohisto-
chemistry for L1.1 was performed on cross sections of brain-
stem and spinal cord after application of different
morpholinos. In lesioned animals that did not receive mor-
pholinos, the number of L1.1-immunopositive cell profiles
was strongly increased in brainstem nuclei with spinal projec-
tions (Fig. 1a,b,e), confirming previous observations on L1.1
mRNA regulation (Becker et al., 1998).
L1.1-specific morpholino, but not a con-
trol morpholino of a random sequence,
reduced the number of L1.1-immuno-
positive cell profiles [e.g., in the anatom-
ically well defined nucleus of the medial
longitudinal fascicle (NMLF)] by maxi-
mally 66% (at 400 ng per animal) in a
dose-dependent manner at 10 d postle-
sion (Kruskal–Wallis test followed by
Dunn’s test, p  0.05 for 400 ng per an-
imal; n  3 animals per concentration).
Testing the efficient concentration at 6
weeks postlesion still indicated a signifi-
cant reduction compared with control
morpholino-treated animals (Mann–
Whitney U test, p  0.05; n  3 animals
per treatment) (Fig. 1b,c,e).
L1.1 immunoreactivity was also in-
creased in the spinal gray matter after spi-
nal cord transection within 1 mm of the
lesion site (Fig. 2a,b,f), probably attribut-
able to the presence of distal segments of
regenerating descending axons and of spi-
nal intrinsic neurons, which also upregu-
lated L1.1 mRNA expression after spinal
lesion (our unpublished observations).
L1.1 morpholino reduced this immunore-
activity within 1 mm caudal to the lesion
site, as indicated by a reduction of relative
immunofluorescence in cross sections of
the lesioned spinal cord (Fig. 2c,d,f) at 10 d
postlesion (Kruskal–Wallis test followed
by Dunn’s test, p 0.05 for L1.1 morpho-
lino vs control morpholino; n  6 ani-
mals). Immunofluorescence within 1 mm
of the lesion site was still reduced at 6
weeks postlesion. In Western blot analysis,
labeling intensity of L1.1 was increased in
lesioned animals and in lesioned animals
that had received control morpholino. In
those animals that received L1.1 morpho-
lino, labeling intensity was always lower
than in control morpholino-treated ani-
mals (n  3 animals per treatment) (Fig.
2g). Four millimeters caudal to the lesion
site, L1.1 immunoreactivity was more
weakly increased after the lesion and was
not significantly reduced after treatment with L1.1 morpholino,
as detected by immunofluorescence and Western blot analysis
(data not shown) at 10 d postlesion. The lack of a significant
reduction of L1.1 immunolabeling at the greater distance may be
explained by the observation that fewer neurons had taken up the
morpholino at 4 mm from the lesion site. Application of fluores-
cently labeled morpholino indicated approximately four times
fewer neurons that took up the morpholino per spinal cross sec-
tion 4 mm caudal to the application site than 1 mm caudal to it
(data not shown). Thus, L1.1 morpholino reduces L1.1 protein
expression in brainstem neurons with spinal axons and near the
spinal lesion site for at least 6 weeks postlesion.
To exclude a possible toxic effect of the morpholinos on cell
survival, brainstem neurons were retrogradely traced by applica-
tion of rhodamine dextran to the transection site together with
Figure 2. L1.1 morpholino reduces L1.1 immunolabeling caudal to a spinal transection site at 10 d postlesion. a–e, Immuno-
fluorescence for L1.1 is increased 1 mm caudal to a spinal lesion site in lesioned animals ( b) and lesioned animals that received
control morpholino ( c), but not in L1.1 morpholino (mo)-treated animals ( d), compared with unlesioned controls ( a) at 10 d
postlesion. In e, the primary antibody (1°) was omitted on a spinal cross section from a lesioned animal. f, Quantification of L1.1
immunofluorescence in spinal cross sections 1 mm caudal to the lesion site indicates a significant reduction by L1.1 morpholino
treatment compared with control morpholino treatment (*p 0.05). g, Western blot analysis of the same spinal region indicates
increased L1.1 immunoreactivity in a band at 200 kDa and another band at 140 kDa, which probably represents a proteolytic
degradation product of L1.1, in lesioned animals (lane 2) and those that had received the control morpholino (lane 3) compared
with unlesioned controls (lane 1). Upregulation of L1.1 was weaker in L1.1 morpholino-treated animals (lane 4). Anti-tubulin
labeling served as a loading control. Scale bar: (in e) a–e, 100m. Error bars represent SEM.
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L1.1-specific morpholinos (400 ng per an-
imal). For example, in the NMLF, neither
control morpholino (42.0 6.34 cell pro-
files per fish; n 5 animals) nor L1.1 mor-
pholino (49.0  5.18; n  4) reduced the
number of neurons compared with le-
sioned animals that only received the
tracer (37.0 11.52; n 4; Mann–Whit-
ney U test, p  0.05) 6 weeks after spinal
cord transection and morpholino applica-
tion. Thus, neurons in the brainstem sur-
vive morpholino application for at least 6
weeks.
To analyze the consequences of the re-
duced expression of L1.1 on functional re-
covery, we established a quantitative test of
locomotor activity. We measured the total
distance moved of undisturbed fish during
5 min trial periods by automatic video
tracking (see Materials and Methods) (Fig.
3). This test exploits the natural behavior
of zebrafish to swim almost constantly. At
1 week after a spinal cord transection, total
distance moved was strongly reduced to
5% (70  22 cm/5 min; n  16) of that
seen in unlesioned fish (1302  302 cm/5
min; n  10) and recovered within 6 weeks postlesion to 57%
(747 137 cm/5 min; Dunn’s multiple comparisons test after
Friedman test, p  0.01). No additional improvement was
observed at 10 weeks postlesion (data not shown). Fish in
which a piece of Teflon tape in the lesion site prevented re-
growth of axons beyond the lesion site showed a total-
distance-moved value of 10% of that in unlesioned fish at 6
weeks postlesion (134  40 cm/5 min; n  6). This differed
significantly from lesioned fish without the block (Mann–Whitney
U test, p 0.05). Sham-lesioned fish, in which the muscle tissue
but not the spinal cord was lesioned, were not strongly impaired
in locomotion and did not show differences between 1 and 10
weeks postlesion (1 week postlesion, 913  137 cm/5 min; 10
weeks postlesion, 898 178 cm/5 min; n 10; Friedman test,p
0.05). Thus, total distance moved is a parameter that is dramati-
cally reduced after a spinal lesion and recovers over time, but not
when regeneration is mechanically blocked.
At 6 weeks postlesion, fish that had received the L1.1 morpho-
lino displayed reduced total-distance-moved values in a dose-
dependent manner to maximally 22% (166 28.6 cm/5 min; 400
ng per fish; n  11 animals per treatment) of the values for
lesioned fish that had received control morpholino (769  174
cm/5 min; Dunn’s multiple comparison test after Kruskal–Wallis
test, p  0.05 for 400 ng per animal) (Fig. 4a). At all of the
concentrations tested (200 – 800 ng per fish), values for control
morpholino-treated animals were not significantly different
from animals that were lesioned but did not receive morpholino
(Kruskal–Wallis test, p  0.05). The reduced values after L1.1
morpholino treatment were not different from those found for
fish in which axon regrowth was blocked with a piece of Teflon
tape (134  39.5 cm/5 min; Mann–Whitney U test, p  0.05).
Thus, L1.1 morpholino specifically reduces locomotor recovery
to an extent that is similar to that in fish in which regrowth of
axons over the lesion site is mechanically blocked.
To find anatomical correlates of this locomotor effect, the
somata of brainstem neurons that regrew an axon beyond the
spinal transection site were retrogradely traced in the same fish
that had been tested in the locomotor paradigm. Intraspinal neu-
rons with descending axons rarely regenerated their descending-
axons (5%) (our unpublished observations) and are there-
fore not considered in this analysis. HRP was applied 4 mm
caudal to the spinal transection site to one spinal hemisphere 6
weeks after the lesion (Fig. 4b,c). The total number of cell
profiles filled with HRP in cross sections of the entire brain-
stem of animals that had only received a gelatin foam pledget
was set to 100%. In animals that had received L1.1 morpho-
lino, the number of labeled cell profiles was significantly re-
duced in a dose-dependent manner (to 35  22.1%) com-
pared with control morpholino-treated animals (106 
34.95%; Dunn’s test for multiple comparisons after Kruskal–
Wallis test, p 0.05; 400 ng per animal) (Fig. 4d). Variabilities
(SEM) for different groups are relatively high as a result of
interindividual differences in regenerative success in zebrafish
(Becker et al., 1997), also reported in other systems (Davis et
al., 1990; Bareyre et al., 2004). Regression analysis of all of the
control and L1.1 morpholino-treated animals indicated a sig-
nificant correlation between the number of neuronal profiles
back-labeled in the brainstem and total distance moved (r 
0.61; p 0.001; n 153). Thus, a reduction of axon regrowth
from brainstem neurons occurs at the same concentration at
which total distance moved was significantly reduced, and the
number of brainstem neurons with regenerated axons cor-
relates with the recovery of locomotor function of individual
fish.
The above results suggest a role of regenerated axons from
brainstem neurons for locomotor recovery. To analyze whether
these axons reform synapses in the spinal cord caudal to a lesion
site and whether their number is reduced by L1.1 morpholino
treatment, we performed anterograde tracing. To label only
newly formed synapses of regrown axons of supraspinal origin in
the spinal cord distal to a lesion site, biocytin was applied at the
brainstem–spinal cord junction 6 weeks after spinal cord lesion
and morpholino application (400 ng/fish), 4 mm caudal to the
Figure 3. The total distance moved partially recovers after spinal cord transection. a, Swim track of an unlesioned fish. b, c,
Swim tracks of the same fish, 1 week ( b) and 6 weeks ( c) after spinal cord transection, show recovery of total distance moved. d,
The total distance moved at 6 weeks postlesion is significantly different from values at 1 week postlesion and from values for fish
in which regeneration was mechanically blocked at 6 weeks postlesion (*p 0.05; **p 0.01). Values for fish in which only the
muscle tissue, but not the spinal cord, was cut (sham) is indicated at 10 weeks postlesion. Error bars represent SEM.
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brainstem–spinal cord junction. Anterogradely labeled synapses
were analyzed in cross sections of the entire spinal cord 6 mm
caudal to the brainstem–spinal cord junction, that is 2 mm caudal
to the transection site (Fig. 4e,f). In unlesioned animals, 82.7 
2.59 labeled synaptic profiles per section were found in this loca-
tion (n  3 animals). In lesioned animals that received control
morpholino, the number of labeled synaptic profiles was lower
(53.3  12.76; 63% of the number seen in unlesioned controls;
n 10 animals). This is compatible with the finding that not all
brainstem neurons regenerate their spinal axons (32–51% of all
brainstem neurons compared with unlesioned controls), as re-
ported previously (Becker et al., 1998). L1.1 morpholino treat-
ment of lesioned animals reduced the number of labeled synaptic
profiles to 22.3 5.75 (n 8 animals) (Fig. 4g), which is 43% of
the number observed after treatment of lesioned animals with
control morpholino (n  10 animals; 2 test, p  0.05). The
reduction in synapse number after L1.1 morpholino treatment
reflects the reduction in the number of brainstem neurons with
regenerated spinal axons after L1.1 morpholino treatment to
35% compared with lesioned controls without morpholino ap-
plication or control morpholino application (see above). Thus,
brainstem neurons with spinal axons regrow synapses into the
distal lesioned spinal cord, and their number is reduced after
application of L1.1 morpholino.
Discussion
Our results indicate that the upregulation
of L1.1 is an important part of the regen-
erative response of axotomized brainstem
neurons in adult zebrafish. Reduced re-
growth and synapse formation of regener-
ating axons from the brainstem caudal to a
spinal lesion site may be one cause of the
impaired functional recovery observed af-
ter L1.1 morpholino treatment. However,
because L1.1 morpholino also accumu-
lates in intraspinal neurons and has a
measurable effect on L1.1 expression
near the lesion site, the treatment could
possibly also affect regeneration-related
plasticity of intraspinal circuitry near the
lesion site. An effect of the morpholino
treatment on oligodendrocytes and as-
trocytes is unlikely because we could not
detect L1.1 mRNA expression in puta-
tive oligodendrocytes in the white mat-
ter of the lesioned spinal cord (Becker et
al., 1998), and double labeling with the
astrocyte marker glial fibrillary acidic
protein indicated no L1.1 mRNA expres-
sion in the somata of the radial astro-
cytes (data not shown). In addition, we
describe a method to specifically reduce
gene expression in axotomized neurons
in an adult vertebrate for at least 6 weeks
postlesion using antisense morpholino
oligonucleotides. This method could
also be useful in nonregenerating mam-
mals to reduce expression of inhibitory
molecules in the lesion site (Asher et al.,
2001) or receptors for growth inhibitors
in neurons (Lee et al., 2003), for
example.
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control morpholino at 400 ng per fish. Values are expressed as percentage of the labeled profiles counted in lesioned animals that
had not received morpholino (*p0.05). e–g, The number of anterogradely traced synapses formed by regenerating axons from
the brainstem caudal to a spinal transection site is reduced by L1.1 morpholino treatment. Labeled synapses of supraspinal origin
(arrows) appear much darker than unlabeled synapses (arrowheads) of intraspinal neurons in the caudal spinal cord in control
morpholino- ( e) and L1.1 morpholino-treated ( f) animals. In g, a graphic comparison of the numbers of labeled synapses found in
individual animals is given (bars represent median values; *p 0.05). Scale bars: (in c) b, c, 75m; (in f ) e, f, 1m. Error bars
represent SEM.
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